In 2013, it was reported that MG53 is upregulated in models of insulin resistance and that it modifies insulin signaling by targeting the degradation of the insulin receptor β-subunit and of IRS1 by its ubiquitin E3 ligase activity [27]. Here, INS is linked to Insulin resistance.